Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Aim of the study is to establish in a prospective, randomized clinical trial the activity of
primary chemotherapy containing high dose-methotrexate, alone or combined with high dose
cytarabine, in patients with primary central nervous system lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
International Extranodal Lymphoma Study Group (IELSG)